Zenas BioPharma (ZBIO) news
Recent news
CPBIO renewal of continuing connected transactions, notice of special general meeting
Cancer Prevention & Biotechnology Limited (CPBIO) has announced the renewal of its continuing connected transactions, as disclosed in a recent regulatory filing. The company has also issued a notice of a special general meeting (SGM) to be held on October 30, 2026, for shareholders to consider and…
AInvest Wire · 2d agoCPBIO renewal of continuing connected transactions, notice of special general meeting
AInvest Wire · 2d agoZenas Biopharma, Inc.: Citigroup raises target price to $48 from $41
AInvest Wire · Oct 1, 2026Zenas Biopharma announces upcoming presentations of Obexelimab data in IgG4-related disease at the IgG4ward! 6th international symposium on IgG4-related disease and ACR convergence 2026
AInvest Wire · Sep 22, 2026Zenas Biopharma Inc files for offering of up to 7.0 mln shares of common stock by the selling stockholder - SEC filing
Zenas Biopharma Inc. has filed with the U.S. Securities and Exchange Commission (SEC) for the sale of up to 7.0 million shares of its common stock by the selling stockholder, according to a recent SEC filing [1]. The offering is part of a registered direct offering and does not involve the company…
AInvest Wire · Sep 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.